首页期刊介绍编委会投稿须知电子期刊广告合作联系我们下载专区留言板

 《中国期刊网》《中国学术期刊(光盘版)全文收录》《中国学术期刊综合评价数据库》来源期刊 “万方数据-数字化期刊群”全文上网《中国核心期刊(遴选数据库)收录》《中文科技期刊数据库》来源期刊《龙源期刊网》合作期刊    友情提醒:我刊未委托任何单位、网站或个人代理征稿,以免上当受骗。

位置:首页 >> 电子期刊 >> 正文
质子泵抑制剂治疗功能性消化不良研究进展
作者:宁琳 韦良宏▲ 黄映莲 
单位:(广西钦州市第一人民医院消化二科 钦州535000) 
关键词:质子泵抑制剂 功能性消化不良 
分类号:R57
出版年,卷(期):页码:2019,47(8):612-615
摘要:
基金项目:
广西卫生和计划生育委员会自筹经费科研课题(Z2016074)
作者简介:
参考文献:

[1]  宁琳,韦良宏,陈海东,等.功能性消化不良与代谢综合征及其组分的相关性[J].医学研究杂志,2019,48(1):122-126.
[2]  陈昺,严晶,孙志广.功能性食管胃十二指肠病罗马Ⅳ诊断标准的更新与应用[J].中医学报,2019,34(1):107-111.
[3]  Tomita T,Oshima T,Fukui H,et al.Role of acid in functional dyspepsia[J].Nihon Rinsho,2015,73(7):1202-1208.
[4]  Nakata-Fukuda M,Hirata T,Keto Y,et al.Inhibitory effect of the selective serotonin 5-HT3 receptor antagonist ramosetron on duodenal acidification-induced gastric hypersensitivity in rats[J].Eur J Pharmacol,2014,731:88-92.
[5]  Suzuki H,Kusunoki H,Kamiya T,et al.Effect of lansoprazole on the epigastric symptoms of functional dyspepsia(ELF study):a multi-centre,prospective,randomized,double-blind,placebo controlled clinical trial[J].United European Gastoente-rology Joural,2013,1(6):445-452.
[6]  邓葵,刘纯伦.胃酸与功能性消化不良[J].胃肠病学和肝病学杂志,2016,25(9):1058-1061.
[7]  赵丹,毛华.功能性消化不良病理生理机制研究进展[J].中华临床医师杂志(电子版),2014,8(15): 2880-2882.
[8]  Yazdanbod A,Salimian S,Habibzadeh S,et al.Effect of Helicobacter pylorieradication in Iranian patients with functional dyspepsia: a prospective,randomized,placebo-controlled trial[J].Arch med sci,2015,11(5):964-969.
[9]  毋睿涵,蓝宇,何凤,等.幽门螺杆菌感染后功能性消化不良患者的胃黏膜肥大细胞变化[J].中华消化杂志,2018,38(6):371-376.
[10] Meng WP,Wang ZQ,Deng JQ,et al.The Role of H.pylori CagA in Regulating Hormones of Functional Dyspepsia Patients[J].Gastroenterol Res Pract,2016,2016:7150959.
[11] Kawamura Y,Funaki Y,Yoshimine T,et al.Characteristics and Predictive Factor of Helicobacter pylori-Associated Functional Dyspepsia in Japanese Patients[J].Digestion,2019,10:1-9.
[12] 黄绍树.根除幽门螺杆菌治疗与功能性消化不良症状的关系[J].医学综述,2015,21(23):4394-4396.
[13] 中华医学会消化病学分会胃肠动力学组,中华医学会消化病学分会胃肠功能性疾病协作组.中国功能性消化不良专家共识意见(2015年,上海)[J].中华消化杂志,2016,36(4):217-229.
[14] 安婧,刘诗.功能性胃肠病罗马Ⅳ诊断标准解读[J].医学新知杂志,2017,27(5):501-502.
[15] Vanheel H,Tack J.Therapeutic options for functional dyspepsia[J].Digestive diseases (Basel,Switzerland),2014,32(3):230-234.
[16] 张旭栋,范一宏,沈佳佳,等.不同作用机制药物对功能性消化不良疗效特点的对照研究[J].胃肠病学,2017,22(8):469-473.
[17] 邓葵.质子泵抑制剂治疗功能性消化不良的临床研究[D].重庆:重庆医科大学,2016.
[18] Russo F,Chimienti G,Clemente C,et al.Gastric Activity and Gut Peptides in Patients With Functional Dyspepsia: Postprandial Distress Syndrome Versus Epigastric Pain Syndrome[J].J Clin Gastroenterol,2017,51(2):136-144.
[19] Rasmussen S,Susanne TH,Henriksen SL,et al.Overlap of syruptoms of gastroesophageal reflux disease,dyspepsia and irritable bowel syndrome in the general population[J].Scand J Gastroenterol,2015,50(2):162-169.
[20] Revaiah PC,Kochhar R,Rana SV,et al.Risk of small intestinal bacterial overgrowth in patients receiving proton pump inhibitors versus proton pump inhibitors plus prokinetics[J].JGH Open,2018,2(2):47-53.
[21] Iwakiri R,Tominaga K,Furtuta K,et al.Randomised clinical trial:rabeprazole improves symptoms in patients with functional dyspepsia in Japan[J].Aliment Pharmacol Ther,2013,38(7): 729-740.
[22] Pinto-Sanchez MI,Yuan Y,Hassan A,et al.Proton pump inhibitors for functional dyspepsia[J].The Cochrane database of systematic reviews,2017,11:CD011194.
[23] Isshi K,Matsuhashi N,Joh T,et al.Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational study[J].J Gastroenterol,2019,54(6):492-500.
[24] Takeuchi T,Takahashi Y,Kawaguchi S,et al.Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor[J].J Gastroenterol Hepatol,2018,33(3):623-630.
[25] Mayanagi S,Kishino M,Kitagawa Y,et al.Efficacy of acotiamide in combination with esomeprazole for functional dyspepsia refractory to proton-pump inhibitor monotherapy[J].Tohoku J Exp Med,2014,234(3):237-240.
[26] Jaruvongvanich V,Poonsombudlert K,Ungprasert P.Vonoprazan versus proton-pump inhibitors for gastric endoscopic submucosal dissection-induced ulcers:a systematic review and meta-analysis[J].European journal of gastroenterology & hepatology,2018,30(12): 1416-1421.
[27] Asaoka D,Nagahara A,Hojo M,et al.Efficacy of a potassium-competitive acid blocker for improving symptoms in patients with reflux esophagitis,non-erosive reflux disease,and functional dyspepsia[J].Biomed Rep,2017,6(2):175-180.
[28] Tomita T,Oshima T,Miwa H,et al.New Approaches to Diagnosis and Treatment of Functional Dyspepsia[J].Curr Gastroenterol Rep,2018,20(12):55.
[29] Shan J,Lei H,Shi W,et al.High Serum Pepsinogen I and beta Helicobacter pylori Infection Are Risk Factors for Aspirin-Induced Gastroduodenal Injury[J].Dig Dis,2018,36(1):66-71.
[30] Auesomwang C,Maneerattanaporn M,Chey WD,et al.Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication[J].Journal of gastroenterology and hepatology,2018,33(11):1822-1828.
[31] 刘军浩,康海锋,李海燕,等.预先使用雷贝拉唑对幽门螺杆菌根除率影响的研究[J].胃肠病学,2013,18(3):360-362.

服务与反馈:
文章下载】【加入收藏

 右江民族医学院附属医院《右江医学》编辑部版权所有 CopyRight:www.yjyx.org All Rights Reserved.
本网站所刊登的各种新闻﹑信息、材料和各种稿件,版权均归本编辑部所有,未经协议授权,禁止转载、禁止下载使用。
本网站由右江民族医学院附属医院《右江医学》编辑部及博科思网络技术(北京)有限公司共同维护
编辑部电话/传真:0776-2825575;网站技术支持电话:010-68713668-9088
地址:广西百色市中山二路18号,邮编:533000
备案号:桂ICP备06012708号-3      公安局备案号:45100202000267号